These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17673939)

  • 41. Antibody-Drug Conjugates: A New Therapeutic Approach for Triple-Negative Breast Cancer.
    Al Jarroudi O; El Bairi K; Curigliano G; Afqir S
    Cancer Treat Res; 2023; 188():1-27. PubMed ID: 38175340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.
    Chen B; Yu P; Chan WN; Xie F; Zhang Y; Liang L; Leung KT; Lo KW; Yu J; Tse GMK; Kang W; To KF
    Signal Transduct Target Ther; 2024 Jan; 9(1):6. PubMed ID: 38169461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody-Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?
    De Santis P; Sanna V; Perrone M; Guarini C; Santoro AN; Laface C; Carrozzo D; Oliva GR; Fancellu A; Fedele P
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer.
    Bhardwaj PV; Abdou YG
    Oncologist; 2023 Oct; 28(10):832-844. PubMed ID: 37597245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZnT 9 Involvement in Estradiol-Modulated Zinc Homeostasis of the Human Follicular Microenvironment.
    Lu H; Wang X; Zhang X; Yu W; Guo X; Wang R; Xie C; Ma J; Wang S
    Biol Trace Elem Res; 2024 May; 202(5):1901-1909. PubMed ID: 37578601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structures and coordination chemistry of transporters involved in manganese and iron homeostasis.
    Ray S; Gaudet R
    Biochem Soc Trans; 2023 Jun; 51(3):897-923. PubMed ID: 37283482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Systematic Study on Zinc-Related Metabolism in Breast Cancer.
    Qu Z; Liu Q; Kong X; Wang X; Wang Z; Wang J; Fang Y
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody-Drug Conjugate Revolution in Breast Cancer: The Road Ahead.
    Grinda T; Rassy E; Pistilli B
    Curr Treat Options Oncol; 2023 May; 24(5):442-465. PubMed ID: 36966267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Zinc's Association with the CmPn/CmP Signaling Network in Breast Cancer Tumorigenesis.
    Renteria M; Belkin O; Aickareth J; Jang D; Hawwar M; Zhang J
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evolving therapeutic landscape of antibody-drug conjugates in breast cancer.
    Chen N; Michaels E; Howard F; Nanda R
    Expert Rev Anticancer Ther; 2022 Dec; 22(12):1325-1331. PubMed ID: 36408586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Divalent Metal Uptake and the Role of ZIP8 in Host Defense Against Pathogens.
    Samuelson DR; Haq S; Knoell DL
    Front Cell Dev Biol; 2022; 10():924820. PubMed ID: 35832795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer.
    Jones S; Farr G; Nimmanon T; Ziliotto S; Gee JMW; Taylor KM
    Explor Target Antitumor Ther; 2022 Apr; 3(2):224-239. PubMed ID: 35591900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.
    Sheyi R; de la Torre BG; Albericio F
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of SLC39A6 in the development and progression of liver cancer.
    Wan Z; Wang X
    Oncol Lett; 2022 Mar; 23(3):77. PubMed ID: 35111246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.
    Bianchini G; De Angelis C; Licata L; Gianni L
    Nat Rev Clin Oncol; 2022 Feb; 19(2):91-113. PubMed ID: 34754128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zinc Signaling in the Mammary Gland: For Better and for Worse.
    Chakraborty M; Hershfinkel M
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fear-of-intimacy-mediated zinc transport controls fat body cell dissociation through modulating Mmp activity in Drosophila.
    Wei T; Ji X; Yu Q; Li G; Wu L; Gao Y; Xiao G
    Cell Death Dis; 2021 Sep; 12(10):874. PubMed ID: 34564691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zinc Favors Triple-Negative Breast Cancer's Microenvironment Modulation and Cell Plasticity.
    Vogel-González M; Musa-Afaneh D; Rivera Gil P; Vicente R
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational analysis of sense-antisense chimeric transcripts reveals their potential regulatory features and the landscape of expression in human cells.
    Mukherjee S; Detroja R; Balamurali D; Matveishina E; Medvedeva YA; Valencia A; Gorohovski A; Frenkel-Morgenstern M
    NAR Genom Bioinform; 2021 Sep; 3(3):lqab074. PubMed ID: 34458728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
    Althobiti M; El-Sharawy KA; Joseph C; Aleskandarany M; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Oct; 189(3):621-630. PubMed ID: 34453638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.